Q&A on RSV Vaccine Candidates for Older Adults factcheck.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from factcheck.org Daily Mail and Mail on Sunday newspapers.
GSK s vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people 60 and older, as the drugmaker races against Pfizer to bring to market the first vaccine for RSV.
FDA Advisors Recommend GSK's RSV Vaccine for Older Adults, But Flag Potential Safety Risks nbcphiladelphia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcphiladelphia.com Daily Mail and Mail on Sunday newspapers.